Logo - springer
Slogan - springer

Medicine - Nephrology | The Kidney in Heart Failure

The Kidney in Heart Failure

Bakris, George L. (Ed.)

2012, XIV, 250 p.

Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$159.00

(net) price for USA

ISBN 978-1-4614-3694-2

digitally watermarked, no DRM

Included Format: PDF and EPUB

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$209.00

(net) price for USA

ISBN 978-1-4614-3693-5

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

Softcover
Information

Softcover (also known as softback) version.

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$209.00

(net) price for USA

ISBN 978-1-4899-9811-8

free shipping for individuals worldwide

usually dispatched within 3 to 5 business days


add to marked items

  • Few published books on this topic
  • Complete coverage of topic
  • Contributions by cardiologists and nephrologists

Chronic Kidney Disease (CKD) is a recognized risk factor for cardiovascular events and death.  The coexistence of CKD and heart failure is increasing in prevalence worldwide and requires a unique and subtle approach to patient management.

 

The Kidney in Heart Failure focuses on the changes that occur in kidney physiology as a function of a failing heart.  This comprehensive resource covers epidemiology, pathophysiology, management of kidney disorders and advances in nephropathy management.  In addition, the latest therapies, common heart failure dilemmas and kidney disease markers are included.  Each chapter is co-authored by a Nephrologist and Cardiologist, offering a unified perspective to these chronic conditions.

 

This indispensible volume provides the reader with the depth-of-knowledge needed for assessing and treating the cardio renal patient.

Content Level » Professional/practitioner

Keywords » anemia - diabetes - heart failure - kidney disease

Related subjects » Cardiology & Angiology - Nephrology

Table of contents 

Foreword                   Peter A. McCulloughPrefacePart One                     Epidemiology

Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                    Ruth C. Campbell and Ali Ahmed

Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                    What is the best way to achieve and what is the desired hemoglobin?

                                    Tejas V. Patel and Ajay K. Singh

 Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

PrefacePart One                     Epidemiology

Chapter 1                    Epidemiology of Chronic Kidney Disease in Heart Failure

                                    Ruth C. Campbell and Ali Ahmed

Chapter 2                    Anemia and Cardiovascular Risk in the Kidney Disease Patients:

                                    What is the best way to achieve and what is the desired hemoglobin?

                                    Tejas V. Patel and Ajay K. Singh

 Part Two                    PathophysiologyChapter 3                    Renal Hemodynamic Changes in Heart Failure

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

                                    Ivana Lazich and George L. Bakris

Chapter 4                    Changes in Kidney Function Following Heart Failure Treatment:  Focus on RAS                                       Blockade

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

                                    Mohammed Shakaib and George L. Bakris

Chapter 5                    Extracellular Fluid Volume in the Hypoalbuminemic Diabetic Patient

                                    Biff F. Palmer

Chapter 6                    B-Type Natriuretic Peptide: Beyond Diagnostic Applications

                                    Ivan D. Hanson and Peter A. McCullough

 

Part Three                 Management of Kidney Associated Clinical Problems

Chapter 7                    Hyperkalemia Risk and Treatment of Heart Failure

                                    Julian Segura and Luis M. Ruilope

Chapter 8                    Management of Heart Failure with Renal Artery Ischaemia

                                    Andrew K. Roy and Patrick Murray

Chapter 9                    Renal Consequences of Prostaglandin Inhibition in Heart Failure

                                    Eric M. Brown, Daniel J. Salzberg, Matthew R. Weir

Chapter 10                  Edema Mechanisms in the Heart Failure Patient and Treatment Options

                                    Domenic A. Sica

Chapter 11                  Ultrafiltration and Heart Failure

                                    Paul Chacko, Donald Kikta Jr., William T. Abraham

 

Part Four                   Advances in Nephropathy Management: Influences on CVD Risk

Chapter 12                  Combination Therapy in Hypertension Treatment

                                    Raymond V. Oliva and George L. Bakris

Chapter 13                  Medication Adherence in Heart Failure

                                    Daniel E. Hilleman and Jennifer A. Campbell

Chapter 14                  New Markers of Vascular Risk

                                    David Davidson and Michael H. Davidson

Chapter 15                  Dietary Paradoxes to Optimize CV Risk Management in CKD

                                    Raghu V. Durvasula and Katherine R. Tuttle

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Nephrology.